Organization
Merck KGaA
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Merck KGaA
... Rockland, Massachusetts - EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, today announced that it ...
... profiles 113 companies including many key and niche players such as: - Merck KgaA - Enzo Life Sciences, Inc. - Bio-Rad Laboratories, Inc. - BioLegend, ...
... Merck KGaA, Darmstadt, Germanytoday announced that its Massachusetts-based business sectors, EMD Serono and ...
... Partnered programmes - In May, received a EUR15 million milestone payment from Merck KGaA for the completion of a pre-clinical package for ALX-1141 targeting ADAMTS-5 ...
... Darmstadt, Germany - Merck, a leading science and technology company, today launched the new Stericup Quick ...
... Biotechnology Inc. - Eppendorf AG - Danaher Corporation - GE Healthcare - Merck KGaA - Thermo Fisher Scientific, Inc. - Sartorius AG Visiongain's study is ...
... today announced that its wholly owned subsidiary, Orexigen Therapeutics Ireland Ltd., and Merck KGaA, Darmstadt, Germany have executed a distributorship agreement for Contrave® (naltrexone HCl ...
... EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the U.S. and Canada, received approval for a ...
... that will allow certain multiple sclerosis or breast cancer patients access to Merck KGaA's Mavenclad or Roche's Perjeta, respectively. NHS England head Simon Steven announced ...
... with a maximum of 20 days of oral treatment over two years Merck, a leading science and technology company, today announced that the National Institute ...
... EMD Serono, the biopharmaceutical business of Merck KGaA, Darmstadt, Germany, in the US and Canada, announced the results of ...
... agreement announced last year between Debiopharm International SA and the alliance between Merck KGaA, Darmstadt, Germany, which operates as EMD Serono in the US and ...
... Merck, a leading science and technology company and the Lupus Foundation of America ...
... Darmstadt, Germany - Merck, a leading science and technology company, today announced the signing of a ...
... Merck KGaA, Darmstadt, Germany, a leading science and technology company which operates its ...
... Darmstadt, Germany - Merck, a leading science and technology company, today announced the signing of a ...
... reflecting the continued expansion of customers and service offerings.Active discussions with partner Merck KGaA to extend the CRINONE® Progesterone Gel agreement are progressing, and the ...
... Qualcomm Incorporated, and M Ventures, the strategic, corporate venture capital arm of Merck KGaA, Darmstadt, Germany, a leading science and technology company. The announcement was ...
... for our customers. For additional information about the company, please visithttp://www.samsungbiologics.com. All Merck news releases are distributed by email at the same time they become ...
... If you thought Merck KGaA would press pause on selling its consumer health unit until Pfizer’s ...
... SVP of market access & customer solutions. Robert Truckenmiller joined EMD Serono, Merck KGaA’s biopharma business in North America, last July as VP of market ...
... plc, AstraZeneca plc, AbbVie Inc., Amgen Inc., Lilly, Bristol-Myers Squibb, Novo Nordisk, Merck KGaA, Allergan, Plc, Boehringer Ingelheim GmbH, Astellas Pharma Inc., Teva Pharmaceutical Industries ...
... key players operating in this industrial microbiology market comprises of Sartorius AG, Merck KGaA, QIAGEN, bioMérieux SA, Bio-Rad Laboratories Inc, Thermo Fisher Scientific Inc, Becton ...
... by the approval of Bristol-Myers' Yervoy drug for melanoma, BMS's Opdivo and Merck's Keytruda. Over the next decade, immunotherapies will be the backbone of cancer ...
... conducted under a clinical collaboration agreement announced last year between Vaccinex and Merck KGaA, Darmstadt, Germany. The clinical trial, short-named "CLASSICAL Lung", is a multi-center, ...
... could be sealed around the middle of 2018, the source said. Germany’s Merck KGaA is also looking to divest its consumer health business and has ...
... Darmstadt, Germany - Merck, a leading science and technology company, has recognized a group of outstanding ...
... Darmstadt, Germany - Merck, a leading science and technology company, today announced that the Canadian Patent ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤